MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

June 25, 2018

CLDA number: CLDA (18)A/03

Date issued: 25th June 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for certain batches of:

Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

PL number: PL04483/0071

Britannia Pharmaceuticals Ltd is recalling certain batches of the above because of increased crystallisation of the active ingredient which may affect the delivery of the full dose.

To view the alert please visit the GOV.UK website.



Posted in:


More Latest News >

Self Care Week 2019

Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families,...

Final CPCS service spec published

Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community...

Ask PSNC: Flu FAQs

The services team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are...